Movano Inc. (NASDAQ:MOVE – Get Free Report) CTO Michael Aaron Leabman sold 2,076 shares of the firm’s stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $6.94, for a total value of $14,407.44. Following the transaction, the chief technology officer directly owned 29,484 shares in the company, valued at approximately $204,618.96. This represents a 6.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Michael Aaron Leabman also recently made the following trade(s):
- On Wednesday, January 14th, Michael Aaron Leabman sold 6,845 shares of Movano stock. The stock was sold at an average price of $6.66, for a total value of $45,587.70.
- On Monday, January 12th, Michael Aaron Leabman sold 3,377 shares of Movano stock. The stock was sold at an average price of $7.01, for a total transaction of $23,672.77.
- On Friday, January 9th, Michael Aaron Leabman sold 783 shares of Movano stock. The stock was sold at an average price of $7.27, for a total transaction of $5,692.41.
- On Thursday, January 8th, Michael Aaron Leabman sold 3,593 shares of Movano stock. The shares were sold at an average price of $7.26, for a total transaction of $26,085.18.
- On Wednesday, January 7th, Michael Aaron Leabman sold 3,293 shares of Movano stock. The shares were sold at an average price of $7.34, for a total transaction of $24,170.62.
Movano Stock Up 1.8%
Shares of NASDAQ:MOVE opened at $7.16 on Friday. The stock has a market cap of $5.94 million, a PE ratio of -0.66 and a beta of 0.79. The company’s fifty day moving average is $8.97 and its 200 day moving average is $7.56. Movano Inc. has a 52 week low of $4.67 and a 52 week high of $58.76.
Movano News Roundup
Here are the key news stories impacting Movano this week:
- Positive Sentiment: Institutional interest: Citadel Advisors disclosed a new, small stake in Movano (49,262 shares), which signals some institutional conviction and provides modest demand support for the thinly traded name. MarketBeat MOV E profile
- Positive Sentiment: Falling short interest: short interest declined in late December (helping reduce one technical headwind and lowering one source of immediate downside pressure). MarketBeat short interest
- Neutral Sentiment: Broader market/geopolitical weakness: wider market pullbacks and geopolitical headlines are hitting small-cap and tech names harder today, likely amplifying Movano’s move. This is a market-driven headwind rather than company-specific news. RTT News: Market Move
- Negative Sentiment: Clustered insider selling: CTO Michael Leabman sold multiple tranches this month (e.g., 6,845 shares on Jan. 14 at ~$6.66; additional sales Jan. 12–13). Large, concentrated insider sales in a tiny, low‑float stock weigh heavily on sentiment and can trigger further price pressure. SEC filing (Leabman)
- Negative Sentiment: Additional insider sales: CFO Jeremy Cogan also disclosed recent sales (including 8,218 shares on Jan. 6), further reducing insider ownership and reinforcing negative market perception. SEC filing (Cogan)
- Negative Sentiment: Weak fundamentals and tiny scale: the recent quarter showed a large EPS loss despite beating the consensus loss, with essentially negligible revenue (~$0.08M versus the street estimate). For a micro‑cap with a market cap in the single‑digit millions and low liquidity, execution risk and potential dilution remain real concerns. Earnings summary
- Negative Sentiment: Analyst/structural headwinds: small market cap, thin volume, and a consensus skewed toward “Sell” make sustained rebounds difficult absent clear operational progress or meaningful new revenue evidence. Company profile & ratings
Institutional Investors Weigh In On Movano
A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC bought a new stake in shares of Movano Inc. (NASDAQ:MOVE – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 16.64% of the company’s stock.
Analyst Ratings Changes
MOVE has been the topic of a number of analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Movano in a research note on Wednesday, October 8th. Wall Street Zen downgraded shares of Movano from a “hold” rating to a “sell” rating in a research note on Saturday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.
View Our Latest Report on Movano
About Movano
Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.
Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.
See Also
- Five stocks we like better than Movano
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.
